Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 38

1.

High affinity anti-Internalin B VHH antibody fragments isolated from naturally and artificially immunized repertoires.

Gene RW, Kumaran J, Aroche C, van Faassen H, Hall JC, MacKenzie CR, Arbabi-Ghahroudi M.

J Immunol Methods. 2015 Jan;416:29-39. doi: 10.1016/j.jim.2014.10.009. Epub 2014 Nov 8.

PMID:
25450000
2.

In situ proteolysis, crystallization and preliminary X-ray diffraction analysis of a VHH that binds listeria internalin B.

Huh I, Gene R, Kumaran J, MacKenzie CR, Brooks CL.

Acta Crystallogr F Struct Biol Commun. 2014 Nov;70(Pt 11):1532-5. doi: 10.1107/S2053230X1402010X. Epub 2014 Oct 25.

PMID:
25372824
3.

Macitentan and morbidity and mortality in pulmonary arterial hypertension.

Pulido T, Adzerikho I, Channick RN, Delcroix M, Galiè N, Ghofrani HA, Jansa P, Jing ZC, Le Brun FO, Mehta S, Mittelholzer CM, Perchenet L, Sastry BK, Sitbon O, Souza R, Torbicki A, Zeng X, Rubin LJ, Simonneau G; SERAPHIN Investigators.

N Engl J Med. 2013 Aug 29;369(9):809-18. doi: 10.1056/NEJMoa1213917.

4.

[Guidelines for COPD prevention, diagnosis and treatment in Argentina].

Figueroa Casas JC, Schiavi E, Mazzei JA, López AM, Rhodius E, Ciruzzi J, Sívori M; Grupo Recomendaciones De EPOC; Asociacion Argentina De Medicina Respiratoria.

Medicina (B Aires). 2012;72 Suppl 1:1-33. Spanish.

5.

Tiotropium as a first maintenance drug in COPD: secondary analysis of the UPLIFT trial.

Troosters T, Celli B, Lystig T, Kesten S, Mehra S, Tashkin DP, Decramer M; Uplift Investigators.

Eur Respir J. 2010 Jul;36(1):65-73. doi: 10.1183/09031936.00127809. Epub 2010 Feb 25.

6.

Efficacy and safety of ipratropium bromide/albuterol delivered via Respimat inhaler versus MDI.

Zuwallack R, De Salvo MC, Kaelin T, Bateman ED, Park CS, Abrahams R, Fakih F, Sachs P, Pudi K, Zhao Y, Wood CC; Combivent Respimat Inhaler Study Group.

Respir Med. 2010 Aug;104(8):1179-88. doi: 10.1016/j.rmed.2010.01.017. Epub 2010 Feb 20.

7.

Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial.

Decramer M, Celli B, Kesten S, Lystig T, Mehra S, Tashkin DP; UPLIFT investigators.

Lancet. 2009 Oct 3;374(9696):1171-8. doi: 10.1016/S0140-6736(09)61298-8. Epub 2009 Aug 27.

PMID:
19716598
8.

Severe exacerbations and decline in lung function in asthma.

O'Byrne PM, Pedersen S, Lamm CJ, Tan WC, Busse WW; START Investigators Group.

Am J Respir Crit Care Med. 2009 Jan 1;179(1):19-24. doi: 10.1164/rccm.200807-1126OC. Epub 2008 Oct 31. Erratum in: Am J Respir Crit Care Med. 2010 Oct 1;182(7):983-4.

PMID:
18990678
9.

A 4-year trial of tiotropium in chronic obstructive pulmonary disease.

Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, Decramer M; UPLIFT Study Investigators.

N Engl J Med. 2008 Oct 9;359(15):1543-54. doi: 10.1056/NEJMoa0805800. Epub 2008 Oct 5.

10.

The Inhaled Steroid Treatment As Regular Therapy in Early Asthma (START) study 5-year follow-up: effectiveness of early intervention with budesonide in mild persistent asthma.

Busse WW, Pedersen S, Pauwels RA, Tan WC, Chen YZ, Lamm CJ, O'Byrne PM; START Investigators Group.

J Allergy Clin Immunol. 2008 May;121(5):1167-74. doi: 10.1016/j.jaci.2008.02.029. Epub 2008 Apr 11.

PMID:
18405951
11.

Effects of early intervention with inhaled budesonide on lung function in newly diagnosed asthma.

O'Byrne PM, Pedersen S, Busse WW, Tan WC, Chen YZ, Ohlsson SV, Ullman A, Lamm CJ, Pauwels RA; START Investigators Group.

Chest. 2006 Jun;129(6):1478-85.

PMID:
16778264
12.

[Updated Argentine consensus on chronic obstructive pulmonary disease].

Gené RJ, Giugno ER, Abbate EH, Figueroa-Casas JC, Mazzei JA, Schiavi EA.

Medicina (B Aires). 2003;63(5):419-46. Review. Spanish.

PMID:
14628655
13.

Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial.

Pauwels RA, Pedersen S, Busse WW, Tan WC, Chen YZ, Ohlsson SV, Ullman A, Lamm CJ, O'Byrne PM; START Investigators Group.

Lancet. 2003 Mar 29;361(9363):1071-6.

PMID:
12672309
14.

Cardiovascular and respiratory consequences of bilateral involvement of the medullary intermediate reticular formation in syringobulbia.

Heidel KM, Benarroch EE, Gené R, Klein F, Meli F, Saadia D, Nogués MA.

Clin Auton Res. 2002 Dec;12(6):450-6.

PMID:
12598949
15.

[Rendu-Osler-Weber syndrome. Pulmonary arteriovenous fistulas. A report of three cases].

Gómez Tejada RA, Gené RJ, Faure C, Rossi S, Vollberg V, Rébora K.

Arch Bronconeumol. 2002 Dec;38(12):599-602. Spanish.

16.

Respiratory effects of halothane in a patient with refractory status asthmaticus.

Revich LR, Grinspon SG, Paredes C, Moreno E, Gené R, Jorge MA.

Pulm Pharmacol Ther. 2001;14(6):455-60.

PMID:
11782125
17.

Effects of supplemental oxygen during activity in patients with advanced COPD without severe resting hypoxemia.

Jolly EC, Di Boscio V, Aguirre L, Luna CM, Berensztein S, Gené RJ.

Chest. 2001 Aug;120(2):437-43.

PMID:
11502641
18.

Community-acquired pneumonia: etiology, epidemiology, and outcome at a teaching hospital in Argentina.

Luna CM, Famiglietti A, Absi R, Videla AJ, Nogueira FJ, Fuenzalida AD, Gené RJ.

Chest. 2000 Nov;118(5):1344-54.

PMID:
11083685
19.

[Use of trovafloxacin therapy in community-acquired pneumonia].

Luna CM, Gené RJ.

Medicina (B Aires). 1999;59 Suppl 1:31-8. Spanish.

PMID:
10436552
20.

[Quinolones. Introduction].

Gené RJ, Luna CM.

Medicina (B Aires). 1999;59 Suppl 1:1-2. Spanish. No abstract available.

PMID:
10436547
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk